The FDA’s Analytical Testing Guidance: What It Means for the Tobacco Industry
What you need to know about the U.S. Food and Drug Administration's (FDA) Final Guidance and how McKinney Specialty Labs can help you navigate these changes.
What you need to know about the U.S. Food and Drug Administration's (FDA) Final Guidance and how McKinney Specialty Labs can help you navigate these changes.
An overview of the Health Canada Tobacco Control Program's history and upcoming amendments.
The latest issue of Tobacco Reporter features an insightful article that highlights the mission, capabilities, and values of McKinney Specialty Labs.
Nicotine is a chiral compound, meaning that there are two enantiomers or different forms of nicotine: (S)-Nicotine and (R)-Nicotine.
On December 22, 2021, FDA published a request for comments on the newly issued draft guidance for the industry entitled “Validation and Verification. Read our submitted comments!
Recently, the FDA issued marketing denial orders (MDO’s) for two products from Vuse Solo brand, the second most popular brand of electronic cigarettes for young consumers.
As the tobacco industry continues to evolve, regulations have become more stringent, requiring manufacturers to provide comprehensive data on their products' safety and efficacy. Here are some tips to ensure the success of your smokeless tobacco testing.
Discover the importance of HPHC testing in tobacco product regulation. Learn how it helps protect public health, informs consumers, and develops effective reduced-harm strategies in our blog.
McKinney Specialty Labs offers a range of test methods for the collection and analysis of harmful and potentially harmful constituents (HPHCs) in mainstream smoke, sidestream smoke, and tobacco filler.
At McKinney Specialty Labs, we develop in-house methods based on request and industry needs. Read more about our developed methods which are validated in accordance with the following guidelines and regulations.
Read this case study about our latest endeavor to assist a client who has been issued a deficiency letter by the FDA, specifying the necessary actions for additional testing.